SHW
62
-6
IRM
41
3
ZBH
65
3
XYL
35
-2
ROST
57
-3
STX
45
-4
CINF
53
3
UNH
57
-2
K
51
-3
BBY
52
6
M
31
-3
EQR
54
3
IR
63
-3
ETR
65
2
TROW
47
-6
PG
50
2
CSX
57
-4
KHC
9
-4
HCP
56
-8
LRCX
37
-9
SHW
62
-6
IRM
41
3
ZBH
65
3
XYL
35
-2
ROST
57
-3
STX
45
-4
CINF
53
3
UNH
57
-2
K
51
-3
BBY
52
6
M
31
-3
EQR
54
3
IR
63
-3
ETR
65
2
TROW
47
-6
PG
50
2
CSX
57
-4
KHC
9
-4
HCP
56
-8
LRCX
37
-9
Financhill
Back

Syndax Pharmaceuticals Quote, Financials, Valuation and Earnings

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here
Sell
15

SNDX
Syndax Pharmaceuticals

Last Price:
15.82
Seasonality Move:
13.57%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.

Syndax Pharmaceuticals Price Quote

$15.82
-0.01 (-5.78%)
(Updated: November 16, 2024 at 5:39 AM ET)

Syndax Pharmaceuticals Key Stats

Sell
15
Syndax Pharmaceuticals (SNDX) is a Sell
Day range:
$15.50 - $16.91
52-week range:
$14.50 - $25.34
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.91%
Volume:
4.5M
Avg. volume:
1.4M
1-year change:
5.11%
Market cap:
$1.4B
Revenue:
$0
EPS:
$-3.63

How Much Does Syndax Pharmaceuticals Make?

Data Unavailable

Is Syndax Pharmaceuticals Growing As A Company?

Data Unavailable

Syndax Pharmaceuticals Stock Price Performance

What Is Syndax Pharmaceuticals 52-Week High & Low?

Syndax Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Syndax Pharmaceuticals?

Is Syndax Pharmaceuticals Cash Flow Positive?

  • What Is SNDX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$258.9M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $264.4M
  • What Is Syndax Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32.9M

Syndax Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    SNDX return on invested capital is -67.33%
  • What Is Syndax Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -60.43%
  • What Is SNDX Return On Equity?
    ROE is a measure of profitability and is -67.33%

Syndax Pharmaceuticals Earnings Date & Stock Price

Syndax Pharmaceuticals Competitors

Syndax Pharmaceuticals Dividend Yield

Syndax Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 7.57%
Revenue: 0% 48.83%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 35.14
Upside from Last Price: 122%

Major Shareholders

  • How many SNDX shares are owned by institutional investors?
    132.2M SNDX shares are owned by institutional investors
  • How many SNDX shares are owned by insiders?
    812.3K SNDX shares are owned by insiders